We propose that by promoting ubiquitin-dependent proteasomal degradation, SOCS1 expression in tumor cells can potentially increase antigen processing and presentation and thereby increase the efficiency of the cross-dressing pathway and promote antitumor immunity (Figure 2). This evidence concerns the gene SOCS1 and neoplasm.